REG - FIL Limited Medtronic, Inc. Covidien plc - Form 8.3 - [Medtronic Inc] <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 0294TFIL Limited30 September 2014FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE1. KEY INFORMATION
Name of person dealing (Note 1)
FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
MEDTRONIC INC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
29-September-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities
21,908,285 2.23
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
3,500 0.00
Total
21,908,285 2.23
3,500 0.00
This includes a transfer into holdings of 45 shares on the 29th September 2014
(b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(63) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS(Note 4)
Purchases and sales
Purchase/sale
Number of securities
Price per unit
Buy
100
62.78 USD/ Share
Buy
204
62.945 USD/ Share
Buy
2,200
62.8532 USD/ Share
Buy
2,300
62.7843 USD/ Share
Buy
2,800
62.9125 USD/ Share
Buy
5,669
62.9383 USD/ Share
Buy
6,500
62.915 USD/ Share
Buy
9,000
62.8191 USD/ Share
Buy
24,818
62.8489 USD/ Share
Buy
26,709
62.9321 USD/ Share
Buy
400
62.8315 USD/ Share
Buy
371
62.7196 USD/ Share
Buy
400
62.7525 USD/ Share
Buy
800
62.69 USD/ Share
Buy
1,300
62.7077 USD/ Share
Buy
1,300
62.7765 USD/ Share
Buy
4,346
62.7464 USD/ Share
Buy
4,400
62.6895 USD/ Share
Buy
6,100
62.7454 USD/ Share
Buy
40,483
62.7345 USD/ Share
Buy
100
62.6 USD/ Share
Sale
1,100
62.5795 USD/ Share
Sale
100
62.79 USD/ Share
Sale
31
63.33 USD/ Share
Buy
80
63.24 USD/ Share
Sale
21
63.24 USD/ Share
Buy
58
63.22 USD/ Share
Sale
43
63.21 USD/ Share
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached?(Note 9)YES
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as
appropriate)
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Call Option
Written
500
USD 70.00
American
22 November 2014
Call Option
Written
1,000
USD 70.00
American
17 January 2015
Call Option
Written
1,000
USD 67.50
American
22 November 2014
Call Option
Written
1,000
USD 65.00
American
18 October 2014
Date of disclosure
30 September 2014
Contact name
Nina Collomosse
Telephone number
+44 (0)1737 837092
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEKMGFLZGZGDZM
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement